Boston Megan 4
4 · Benitec Biopharma Inc. · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2020-12-09+142,172→ 142,172 totalExercise: $2.98Exp: 2030-12-09→ Common Stock (142,172 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on December 9, 2021, December 9, 2022, and December 9, 2023.